Results of the EPIC (Evaluation of Pimobendan in Cardiomegaly) Study have been published in the Journal of Veterinary Medicine. Click here to access the publication
EPIC: The largest veterinary cardiology study EVER
36 trial centres, 360 dogs, 11 countries, over 5 years
Results show that administration of pimobendan to dogs with mitral valve
disease and echocardiographic and radiographic evidence of cardiomegaly
results in prolongation of preclinical period by approximately
15 months, which represents substantial clinical benefit
The EPIC Trial website will be updated with more information soon!
Further details on the study can be found at the Royal Veterinary College website.